Cargando…
Application of systemic treatment in conversion therapy options for liver cancer
Radical hepatectomy is the main treatment method to improve the prognosis of patients with intermediate and early-stage liver cancer. Most liver cancer patients in China are in the advanced stage at the initial diagnosis, losing the opportunity for surgical treatment. Therefore, it is essential to d...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583895/ https://www.ncbi.nlm.nih.gov/pubmed/36276063 http://dx.doi.org/10.3389/fonc.2022.966821 |
_version_ | 1784813168723230720 |
---|---|
author | Bei, Haoyang Mai, Weiheng Chen, Weifeng Li, Mingyi Yang, Yongguang |
author_facet | Bei, Haoyang Mai, Weiheng Chen, Weifeng Li, Mingyi Yang, Yongguang |
author_sort | Bei, Haoyang |
collection | PubMed |
description | Radical hepatectomy is the main treatment method to improve the prognosis of patients with intermediate and early-stage liver cancer. Most liver cancer patients in China are in the advanced stage at the initial diagnosis, losing the opportunity for surgical treatment. Therefore, it is essential to down-stage unresectable liver cancer to resectable liver cancer clinically, which is an important way to improve patients’ survival and a hotspot of current clinical research. In recent years, with the increase in effective treatment methods for liver cancer, the resection rate of conversion surgery for unresectable advanced liver cancer has been significantly improved, and a growing number of patients benefit from conversion therapy. This article mainly reviews the connotation of conversion therapy for liver cancer, the patient selection, the selection of conversion strategy, the timing of sequential operations, the scheme and safety, etc. |
format | Online Article Text |
id | pubmed-9583895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95838952022-10-21 Application of systemic treatment in conversion therapy options for liver cancer Bei, Haoyang Mai, Weiheng Chen, Weifeng Li, Mingyi Yang, Yongguang Front Oncol Oncology Radical hepatectomy is the main treatment method to improve the prognosis of patients with intermediate and early-stage liver cancer. Most liver cancer patients in China are in the advanced stage at the initial diagnosis, losing the opportunity for surgical treatment. Therefore, it is essential to down-stage unresectable liver cancer to resectable liver cancer clinically, which is an important way to improve patients’ survival and a hotspot of current clinical research. In recent years, with the increase in effective treatment methods for liver cancer, the resection rate of conversion surgery for unresectable advanced liver cancer has been significantly improved, and a growing number of patients benefit from conversion therapy. This article mainly reviews the connotation of conversion therapy for liver cancer, the patient selection, the selection of conversion strategy, the timing of sequential operations, the scheme and safety, etc. Frontiers Media S.A. 2022-10-06 /pmc/articles/PMC9583895/ /pubmed/36276063 http://dx.doi.org/10.3389/fonc.2022.966821 Text en Copyright © 2022 Bei, Mai, Chen, Li and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Bei, Haoyang Mai, Weiheng Chen, Weifeng Li, Mingyi Yang, Yongguang Application of systemic treatment in conversion therapy options for liver cancer |
title | Application of systemic treatment in conversion therapy options for liver cancer |
title_full | Application of systemic treatment in conversion therapy options for liver cancer |
title_fullStr | Application of systemic treatment in conversion therapy options for liver cancer |
title_full_unstemmed | Application of systemic treatment in conversion therapy options for liver cancer |
title_short | Application of systemic treatment in conversion therapy options for liver cancer |
title_sort | application of systemic treatment in conversion therapy options for liver cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583895/ https://www.ncbi.nlm.nih.gov/pubmed/36276063 http://dx.doi.org/10.3389/fonc.2022.966821 |
work_keys_str_mv | AT beihaoyang applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer AT maiweiheng applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer AT chenweifeng applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer AT limingyi applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer AT yangyongguang applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer |